# SCGN

## Overview
The SCGN gene encodes secretagogin, a hexa EF-hand calcium-binding protein that plays a pivotal role in calcium ion signaling and exocytosis. Secretagogin is primarily categorized as a calcium sensor protein due to its ability to undergo conformational changes upon binding calcium ions, which is crucial for its function in various cellular processes. It is predominantly expressed in the cytoplasm of pancreatic beta cells and neuroendocrine tissues, where it regulates insulin secretion and neuroendocrine functions (Rogstam2006Binding; Maj201920). The protein interacts with components of the SNARE complex, such as SNAP-25, to facilitate hormone secretion and synaptic function (Qin2020Structural). Mutations in the SCGN gene have been linked to diseases such as ulcerative colitis and autism spectrum disorder, underscoring its clinical significance in both metabolic and neurodevelopmental contexts (Liu2023SCGN; SifuentesDominguez2019SCGN).

## Structure
Secretagogin (SCGN) is a hexa EF-hand calcium-binding protein characterized by its ability to bind calcium ions through its EF-hand motifs. The primary structure of SCGN includes six EF-hand motifs, which are helix-loop-helix structures essential for calcium coordination (Rogstam2006Binding; Bitto2009X‐ray). In its secondary structure, SCGN exhibits a typical α-helical conformation, as indicated by circular dichroism spectroscopy (Sharma2015Secretagogin).

The tertiary structure of SCGN is modular, consisting of three globular domains, each containing a pair of EF-hand motifs. These domains form a V-shaped molecule with a distinct groove at their interface, stabilized by hydrophobic interactions (Bitto2009X‐ray). The quaternary structure involves dimerization, which is crucial for its function in insulin secretion. This dimerization is facilitated by calcium-induced structural changes and the formation of a disulfide bond between Cys193 residues (Lee2017Calcium).

SCGN undergoes post-translational modifications, such as phosphorylation, which may regulate its function. It also has splice variant isoforms, including secretagogin-R22 and setagin, which differ in their EF-hand domains and calcium-binding capabilities (Alpár2012The).

## Function
Secretagogin (SCGN) is a hexa EF-hand calcium-binding protein that plays a crucial role in calcium ion signaling and exocytosis in human cells. It is primarily active in the cytoplasm and is involved in the regulation of insulin secretion in pancreatic beta cells, as well as in neuroendocrine functions (Rogstam2006Binding; Maj201920). SCGN binds calcium ions with relatively low affinity, which induces significant conformational changes, classifying it as a calcium sensor protein (Rogstam2006Binding).

SCGN interacts with SNAP-25, a component of the SNARE complex, in a calcium-dependent manner, which is essential for its role in exocytosis. This interaction is crucial for the secretion of hormones such as insulin and corticotropin-releasing hormone (Qin2020Structural). SCGN's interaction with SNAP-25 also influences the localization of SNAP-25 to the plasma membrane, which is vital for efficient hormone secretion (Qin2020Structural).

In the nervous system, SCGN is involved in synaptic function and neuronal growth, with implications for neurodevelopmental processes and synapse activity (Qin2020Structural; Maj201920). Its expression in various tissues, including the pancreas, brain, and gastrointestinal tract, highlights its diverse roles in cellular communication and metabolic regulation (Maj201920).

## Clinical Significance
Mutations in the SCGN gene, which encodes the calcium-binding protein secretagogin, have been implicated in several diseases. A homozygous mutation, specifically the R77H substitution, has been linked to early-onset ulcerative colitis in a consanguineous family. This mutation results in a loss of function of the SCGN protein, leading to decreased hormone secretion and altered cellular localization, which increases susceptibility to colitis (SifuentesDominguez2019SCGN). SCGN-deficient mice also show increased susceptibility to DSS-induced colitis, suggesting a protective role of SCGN in maintaining intestinal immune homeostasis (SifuentesDominguez2019SCGN).

SCGN mutations have also been associated with autism spectrum disorder (ASD). Studies have identified SCGN as a risk factor for ASD, with mutations leading to impaired brain development and autism-like behaviors in zebrafish and mice models. These mutations disrupt oxytocin signaling and activate inflammatory pathways, contributing to ASD-like symptoms (Liu2023SCGN). SCGN deficiency results in reduced oxytocin levels and increased pro-inflammatory gene expression, which can be mitigated by oxytocin administration and anti-inflammatory treatments (Liu2023SCGN). These findings highlight the clinical significance of SCGN in both inflammatory bowel disease and neurodevelopmental disorders.

## Interactions
Secretagogin (SCGN) is a calcium-binding protein that participates in various protein interactions, primarily influencing exocytosis and vesicle trafficking. One of its key interaction partners is SNAP-25, a component of the SNARE complex crucial for membrane fusion events. This interaction is calcium-dependent, with a higher affinity in the presence of calcium ions (Rogstam2006Binding). The binding of SCGN to SNAP-25 has been shown to inhibit SNARE-mediated vesicle fusion in vitro, suggesting a regulatory role in exocytosis (Qin2020Structural).

SCGN also interacts with other proteins involved in secretion and cellular processes, such as SNAP-23, DOC2alpha, ARFGAP2, rootletin, KIF5B, β-tubulin, DDAH-2, ATP-synthase, and myeloid leukemia factor 2 (Maj201920). The interaction with DOC2alpha is particularly notable, as it involves specific binding to the linker between the C2A and C2B domains of DOC2alpha, which is unique among the Doc2/Synaptotagmin family (Tu2023Secretagogin).

These interactions highlight SCGN's role in linking calcium signaling to exocytotic processes, particularly in secretory cells like insulin-secreting pancreatic beta cells and stress hormone-releasing neurons (Maj201920).


## References


[1. (Lee2017Calcium) Jae-Jin Lee, Seo-Yun Yang, Jimin Park, James E. Ferrell, Dong-Hae Shin, and Kong-Joo Lee. Calcium ion induced structural changes promote dimerization of secretagogin, which is required for its insulin secretory function. Scientific Reports, August 2017. URL: http://dx.doi.org/10.1038/s41598-017-07072-4, doi:10.1038/s41598-017-07072-4. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-017-07072-4)

[2. (Tu2023Secretagogin) Yingfeng Tu, Jiao Qin, Qiao-Ming Zhang, Tie-Shan Tang, Lifang Wang, and Jun Yao. Secretagogin regulates asynchronous and spontaneous glutamate release in hippocampal neurons through interaction with doc2α. Life Medicine, October 2023. URL: http://dx.doi.org/10.1093/lifemedi/lnad041, doi:10.1093/lifemedi/lnad041. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1093/lifemedi/lnad041)

[3. (Bitto2009X‐ray) Eduard Bitto, Craig A. Bingman, Lenka Bittova, Ronnie O. Frederick, Brian G. Fox, and George N. Phillips. X‐ray structure of danio rerio secretagogin: a hexa‐ef‐hand calcium sensor. Proteins: Structure, Function, and Bioinformatics, 76(2):477–483, February 2009. URL: http://dx.doi.org/10.1002/prot.22362, doi:10.1002/prot.22362. This article has 20 citations.](https://doi.org/10.1002/prot.22362)

[4. (Alpár2012The) Alán Alpár, Johannes Attems, Jan Mulder, Tomas Hökfelt, and Tibor Harkany. The renaissance of ca2+-binding proteins in the nervous system: secretagogin takes center stage. Cellular Signalling, 24(2):378–387, February 2012. URL: http://dx.doi.org/10.1016/j.cellsig.2011.09.028, doi:10.1016/j.cellsig.2011.09.028. This article has 53 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.cellsig.2011.09.028)

[5. (Maj201920) Magdalena Maj, Ludwig Wagner, and Verena Tretter. 20 years of secretagogin: exocytosis and beyond. Frontiers in Molecular Neuroscience, February 2019. URL: http://dx.doi.org/10.3389/fnmol.2019.00029, doi:10.3389/fnmol.2019.00029. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnmol.2019.00029)

[6. (Liu2023SCGN) Zhe Liu, Shuai Tan, Lianyu Zhou, Li Chen, Mingfeng Liu, Wang Wang, Yingying Tang, Qin Yang, Sensen Chi, Peiyan Jiang, Yue Zhang, Yonghua Cui, Junhong Qin, Xiao Hu, Shenglong Li, Qi Liu, Lu Chen, Song Li, Ezra Burstein, Wei Li, Xiaohu Zhang, Xianming Mo, and Da Jia. Scgn deficiency is a risk factor for autism spectrum disorder. Signal Transduction and Targeted Therapy, January 2023. URL: http://dx.doi.org/10.1038/s41392-022-01225-2, doi:10.1038/s41392-022-01225-2. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41392-022-01225-2)

[7. (SifuentesDominguez2019SCGN) Luis F Sifuentes-Dominguez, Haiying Li, Ernesto Llano, Zhe Liu, Amika Singla, Ashish S Patel, Mahesh Kathania, Areen Khoury, Nicholas Norris, Jonathan J Rios, Petro Starokadomskyy, Jason Y Park, Purva Gopal, Qi Liu, Shuai Tan, Lillienne Chan, Theodora Ross, Steven Harrison, K Venuprasad, Linda A Baker, Da Jia, and Ezra Burstein. Scgn deficiency results in colitis susceptibility. eLife, October 2019. URL: http://dx.doi.org/10.7554/elife.49910, doi:10.7554/elife.49910. This article has 19 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.7554/elife.49910)

[8. (Rogstam2006Binding) Annika Rogstam, Sara Linse, Anders Lindqvist, Peter James, Ludwig Wagner, and Tord Berggård. Binding of calcium ions and snap-25 to the hexa ef-hand protein secretagogin. Biochemical Journal, 401(1):353–363, December 2006. URL: http://dx.doi.org/10.1042/bj20060918, doi:10.1042/bj20060918. This article has 80 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bj20060918)

[9. (Qin2020Structural) Jiao Qin, Qi Liu, Zhe Liu, Yun-Zu Pan, Luis Sifuentes-Dominguez, Karolina P. Stepien, Yan Wang, Yingfeng Tu, Shuai Tan, Yuan Wang, Qingxiang Sun, Xianming Mo, Josep Rizo, Ezra Burstein, and Da Jia. Structural and mechanistic insights into secretagogin-mediated exocytosis. Proceedings of the National Academy of Sciences, 117(12):6559–6570, March 2020. URL: http://dx.doi.org/10.1073/pnas.1919698117, doi:10.1073/pnas.1919698117. This article has 26 citations.](https://doi.org/10.1073/pnas.1919698117)

[10. (Sharma2015Secretagogin) Anand Kumar Sharma, Radhika Khandelwal, Yogendra Sharma, and Vangipurapu Rajanikanth. Secretagogin, a hexa ef-hand calcium-binding protein: high level bacterial overexpression, one-step purification and properties. Protein Expression and Purification, 109:113–119, May 2015. URL: http://dx.doi.org/10.1016/j.pep.2015.02.011, doi:10.1016/j.pep.2015.02.011. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.pep.2015.02.011)